scholarly article | Q13442814 |
P356 | DOI | 10.1002/EJHF.240 |
P698 | PubMed publication ID | 25704364 |
P50 | author | Faiez Zannad | Q19631268 |
Stefan D. Anker | Q30310195 | ||
Patrick Rossignol | Q33103963 | ||
Nicolas Girerd | Q56394664 | ||
Luigi Tavazzi | Q64496908 | ||
Jay N. Cohn | Q112435475 | ||
P2093 | author name string | Roberto Latini | |
Inder S Anand | |||
Gianni Tognoni | |||
Serge Masson | |||
Simona Barlera | |||
Francesco Clemenza | |||
Angelo Castelnovo | |||
GISSI-HF and Val-HeFT Investigators | |||
P2860 | cites work | Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials | Q31096498 |
The link of unintentional weight loss to cardiac event-free survival in patients with heart failure | Q34036472 | ||
Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure | Q34093420 | ||
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure | Q34106793 | ||
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study | Q34187927 | ||
Wasting as independent risk factor for mortality in chronic heart failure | Q34421966 | ||
The regulation and measurement of plasma volume in heart failure | Q34708039 | ||
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis | Q36524299 | ||
Cardiac cachexia: a systematic overview | Q37343128 | ||
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss | Q37491629 | ||
Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology | Q38061744 | ||
Mechanisms for cachexia in heart failure | Q38127358 | ||
Impact of obesity and weight loss on cardiac performance and morphology in adults | Q38179545 | ||
Obesity and the obesity paradox in heart failure | Q38179548 | ||
Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox | Q38188322 | ||
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure | Q38195392 | ||
Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram | Q38461247 | ||
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme | Q39361054 | ||
Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution | Q40980556 | ||
The relationship between obesity and mortality in patients with heart failure | Q43723158 | ||
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial | Q44329632 | ||
Increased catabolic activity in adipose tissue of patients with chronic heart failure | Q44672396 | ||
Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox | Q44760161 | ||
Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status | Q45150879 | ||
Analyzing the weight of evidence on the obesity paradox and heart failure--is there a limit to the madness? | Q47219380 | ||
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. | Q55067141 | ||
Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: A prospective study | Q61793901 | ||
Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects | Q61918750 | ||
P433 | issue | 4 | |
P921 | main subject | heart failure | Q181754 |
chronic heart failure | Q11829287 | ||
P304 | page(s) | 424-433 | |
P577 | publication date | 2015-02-22 | |
P1433 | published in | European Journal of Heart Failure | Q5017954 |
P1476 | title | Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials | |
P478 | volume | 17 |
Q87205182 | Adding insult to injury: heart failure and incident cancer |
Q90673843 | Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure |
Q42668863 | Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis. |
Q39752065 | Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology |
Q37594528 | Cardiac Cachexia: Perspectives for Prevention and Treatment |
Q90259014 | Clinical significance of nutritional status in patients with chronic heart failure-a systematic review |
Q91799563 | Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge |
Q38904288 | Dietary Self-management in Heart Failure: High Tech or High Touch? |
Q38726519 | Dietary management of heart failure: room for improvement? |
Q52560610 | Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future. |
Q36408544 | Effect of Obesity and Underweight Status on Perioperative Outcomes of Congenital Heart Operations in Children, Adolescents, and Young Adults: An Analysis of Data from the Society of Thoracic Surgeons Database |
Q37206834 | Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration |
Q26769905 | Focus on renal congestion in heart failure |
Q89414846 | Heart failure in the elderly |
Q64947391 | Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. |
Q57797666 | Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure |
Q34681621 | Muscle wasting and cachexia in heart failure: mechanisms and therapies |
Q49183956 | Muscle wasting and sarcopenia in heart failure and beyond: update 2017. |
Q86872516 | Neuromuscular junction fragmentation and muscle wasting in heart failure: a sharp cut from a Sica sword? |
Q92569650 | Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival |
Q64063186 | Nutritional Considerations of Cardiovascular Diseases and Treatments |
Q58603645 | Observational Evidence for Unintentional Weight Loss in All-Cause Mortality and Major Cardiovascular Events: A Systematic Review and Meta-Analysis |
Q92053510 | Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Registry |
Q39019268 | Publication trends in cachexia and sarcopenia in elderly heart failure patients |
Q50048824 | Publishing in a heart failure journal-where lies the scientific interest? |
Q92462130 | Renal function, electrolytes, and congestion monitoring in heart failure |
Q48511525 | Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure |
Q47311543 | Sex Differences in Muscle Wasting |
Q95837212 | Spironolactone dose in Heart Failure with Preserved Ejection Fraction: findings from TOPCAT |
Q88763819 | The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score |
Q37090681 | Weight Loss in Obese Patients With Heart Failure. |
Search more.